-

Claritas Rx Chief Technology Officer Bhupesh Bajaj Named to PM360 ELITE 100 List

Mr. Bajaj Recognized in the Data Miners Category for Transforming Complex Healthcare Data into Actionable Patient Outcomes

original Claritas Rx Chief Technology Officer Bhupesh Bajaj named to PM360 ELITE 100 List. Mr. Bajaj recognized in the Data Miners category for transforming complex healthcare data into actionable patient outcomes.

Claritas Rx Chief Technology Officer Bhupesh Bajaj named to PM360 ELITE 100 List. Mr. Bajaj recognized in the Data Miners category for transforming complex healthcare data into actionable patient outcomes.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, today announced that Bhupesh Bajaj, Chief Technology Officer, has been named to the prestigious PM360 ELITE 100 list in the Data Miners category. The annual recognition highlights the most exceptional, innovative, and transformative leaders shaping the healthcare and life sciences industries today.

Mr. Bajaj was recognized for his groundbreaking work redefining how data is harnessed to drive meaningful outcomes in specialty healthcare.

Share

Mr. Bajaj was recognized for his groundbreaking work redefining how data is harnessed to drive meaningful outcomes in specialty healthcare. Under his leadership, Claritas Rx has reimagined the Ascend® platform, evolving it into a cloud-hosted SaaS solution that integrates real-world specialty data with advanced analytics, AI, and intelligent case management to generate actionable insights across the patient journey. The result: measurable improvements in patient access and adherence, including higher fill and refill rates and faster response times from specialty pharmacies.

"Bhupesh exemplifies what it means to put patients at the center of everything we build," said Michael Fitzgibbons, CEO of Claritas Rx. "His ability to bridge deep technical expertise with a clear understanding of the business and clinical challenges facing our customers has been instrumental in advancing our platform and, more importantly, in helping more patients get on and stay on the treatments they need. This recognition is well-deserved, and we are proud to have him leading our technology vision."

Winners are profiled in PM360's 2026 ELITE issue. For more information, visit www.pm360online.com.

About Claritas Rx

Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. By uniting the most complete view of the patient journey with purpose-built technologies, we predict and resolve access challenges before they disrupt care. Our intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com.

Contacts

Media Contact:
Emily Brennan
EBrennan@ClaritasRx.com

Industry:

Claritas Rx

Release Versions
English

Contacts

Media Contact:
Emily Brennan
EBrennan@ClaritasRx.com

More News From Claritas Rx

Claritas Rx Introduces Omnichannel CRM to Transform Patient Services and Speed Access to Specialty Therapies

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, today announced the availability of its Patient Services Omnichannel CRM. The new solution enables clients to engage rapidly and consistently across the full patient‑care ecosystem—from specialty and independent pharmacies to hubs, field teams, case managers, and other key stakeholders—accelerating patient support and streamlining communication for a faster, better experience at every stage of care. By unify...

Claritas Rx Unveils Integrated Data and Consent Solution That Drives Higher First Fill Rates and Long-Term Persistence Across Specialty and Rare Brands

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, today announced the availability of its Foundational Data Aggregation with the industry’s first and only patient Consent Clearinghouse™ designed to improve first fill and persistence across specialty and rare disease brands. By unifying data across channels and making it analytics-ready, the solution gives commercial, patient services, and data teams a more reliable, trusted view of the specialty patient jou...

A “Data Deluge” from an Expanding Array of Data Providers is a Significant Rare Market Trend to Watch in 2026

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Claritas Rx, the patient journey experts, today announced the release of a new white paper, Thriving in Turbulence: Strategic Adaptation in the Evolving Specialty and Rare Market. The paper examines how specialty and rare disease manufacturers can build strategic agility amid mounting economic, regulatory, and market access complexity. The white paper outlines five major trends shaping 2026: rising economic volatility and tariff exposure, payer and...
Back to Newsroom